Table 1.
Neurophysiological and ultrasound features of patients.
| Case No. | Age | Ridley and Jopling Classification | Side | Nerve |
|||
|---|---|---|---|---|---|---|---|
| Median | Ulnar | Fibular | Tibial | ||||
| 1 | 55 | TT | R | N | |||
| 21 | 82 | BB | R | Min | Min | M (TD) | M (TD) |
| L | Min | Min | M (TD) | M (TD) | |||
| 31, 2 | 50 | BL | R | – | ⊕ M (TD) | M (PM) | M (PM) |
| L | – | ⊕ M (TD) | A () | A (∅) | |||
| 42 | 53 | LL | R | ⊕ N | M | N | N |
| L | N | M | N | N | |||
| 51 | 40 | BL | R | – | M (TD) | – | – |
| L | – | – | M (TD) | – | |||
| 61, 2 | 43 | BL | R | – | M (TD; PM) | ⊕ A (TD) | – |
| L | – | M (TD) | ⊕ M | ||||
| 72 | 29 | BL | R | Min | M | N | M |
| L | Min | M | N | N | |||
| 81, 2 | 35 | LL | R | ⊕ Min | N | ||
| L | ⊕ M (TD; PM) | N | |||||
| 91, 2 | 57 | LL | R | ⊕ Min | M (PM) | Min | ⊕ M (PM) |
| L | N | ⊕ M (PM) | M | A (TD) | |||
| 101, 2 | 52 | BL | R | M | ⊕ M | M (TD) | M (TD) |
| L | M | ⊕ Min | N | Min | |||
| 111, 2 | 51 | BL | R | M (PM) | ⊕ M (PM) | N | A |
| L | Min | ⊕ M (PM) | N | ⊕ M (PM) | |||
| 121 | 39 | BT | R | Min | N | A | N |
| L | Min | M (PM) | N | N | |||
| 13 | 41 | BL | R | Min | Min | Min | N |
| L | Min | Min | Min | N | |||
| 142 | 52 | LL | R | Min | Min | Min | N |
| L | Min | Min | A | ⊕ N | |||
| 152 | 41 | TT | R | M | N | N | N |
| L | M | ⊕ Min | ⊕ N | N | |||
| 162 | 54 | BT | R | N | ⊕ M | N | N |
| L | N | ⊕ M | N | N | |||
| 171, 2 | 61 | BL | R | M | ⊕ N | ⊕ A | M (TD) |
| L | M | ⊕ N | Min | ⊕ M (TD; PM) | |||
| 181 | 41 | BT | R | Min | M (PM) | Min | N |
| L | N | M (PM) | Min | N | |||
| 191, 2 | 28 | BT | R | N | N | ⊕ M (TD) | Min |
| L | N | Min | N | N | |||
| 201, 2 | 40 | BB | R | A (TD) | M (TD; PM) | M | ⊕ A (TD) |
| L | ⊕ Min | ⊕ M (TD; PM) | ⊕ A | M (TD) | |||
| 211 | 44 | BL | R | Min | Min | M (TD) | M (TD) |
| L | Min | A | A (∅) | M | |||
| 221, 2 | 73 | BL | R | Min | ⊕ M (TD; PM) | A (∅) | ⊕ A (∅) |
| L | Min | Min | A (∅) | ⊕ A (∅) | |||
| 232 | 21 | BL | R | M | N | Min | N |
| L | Min | ⊕ Min | ⊕ N | N | |||
| 241, 2 | 50 | BL | R | ⊕ M | ⊕ M (TD; PM) | ⊕ M | ⊕ M (TD) |
| L | Min | ⊕ M (TD) | ⊕ A (∅) | A (TD) | |||
| 252 | 75 | BT | R | M | Min | N | N |
| L | ⊕ Min | Min | A | N | |||
| 261, 2 | 71 | BL | R | N | ⊕ M (TD; PM) | A | ⊕ M (TD; PM) |
| L | N | ⊕ M | ⊕ A (∅) | ⊕ A (∅) | |||
| 271, 2 | 56 | BT | R | ⊕ M (TD; PM) | A (TD) | A (∅) | A (∅) |
| L | M (TD; PM) | A (TD) | A (∅) | A (∅) | |||
| 281, 2 | 37 | BB | R | ⊕ M | ⊕ A (∅) | ⊕ A (∅) | M |
| L | M (PM) | ⊕ Min | ⊕ A (∅) | ⊕ A | |||
| 291, 2 | 47 | LL | R | M | Min | Min | ⊕ N |
| L | M | ⊕ M | A (∅) | ⊕ M (TD) | |||
| 301, 2 | 51 | BT | R | M (PM) | ⊕ M | N | A |
| L | M | ⊕ Min | N | A | |||
| 311, 2 | 58 | BL | R | Min | ⊕ M | M (TD) | ⊕ A |
| L | Min | Min | ⊕ M (TD) | ⊕ Min | |||
| 32 | 56 | BT | R | M | N | Min | N |
| L | M | N | N | N | |||
| 332 | 59 | BB | R | ⊕ M | ⊕ N | N | N |
| L | M | ⊕ M | N | Min | |||
| 341, 2 | 53 | BL | R | M | M | ⊕ M (TD; PM) | ⊕ M (PM) |
| L | M | ⊕ M | M (TD; PM) | ⊕ M (TD; PM) | |||
| 351 | 74 | BB | R | M | M (TD) | A (TD) | A |
| L | M | M | A (TD) | A | |||
TT: tuberculoid, BT: borderline tuberculoid, BB: borderline, BL: borderline lepromatous, LL: lepromatous, R: right, L: left, N: normal, M: myelinated changes, A: axonal changes, Min: minimal changes, ⊕: presence of color Doppler flow, DT: temporal dispersion, MP: moderate/pronounced myelin changes, ∅: no distal conduction motor action potential.
1
Patients with signs of inflammatory activity at nerve conduction studies.
2
Patients with signs of inflammatory activity at HFUS and CD.